UBS AM
CCRN

UBS AM’s Cross Country Healthcare CCRN Stock Holding History

UBS AM’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$536K Buy
57,049
+115
+0.2% +$1.03K ﹤0.01% 2535
2025
Q4 		$461K Buy
56,934
+761
+1% +$8.31K ﹤0.01% 2334
2025
Q3 		$798K Sell
56,173
-93,567
-62% -$1.24M ﹤0.01% 2083
2025
Q2 		$1.95M Buy
149,740
+33,917
+29% +$466K ﹤0.01% 2151
2025
Q1 		$1.72M Buy
115,823
+8,490
+8% +$146K ﹤0.01% 2059
2024
Q4 		$1.95M Buy
107,333
+7,278
+7% +$98K ﹤0.01% 2060
2024
Q3 		$1.34M Sell
100,055
-3,118
-3% -$46K ﹤0.01% 2234
2024
Q2 		$1.43M Buy
103,173
+39,693
+63% +$628K ﹤0.01% 2181
2024
Q1 		$1.19M Hold
63,480
– – ﹤0.01% 1923
2023
Q4 		$1.44M Buy
63,480
+3,042
+5% +$66K ﹤0.01% 1836
2023
Q3 		$1.5M Sell
60,438
-3,480
-5% -$87.6K ﹤0.01% 1758
2023
Q2 		$1.43M Hold
63,918
– – ﹤0.01% 1839
2023
Q1 		$1.43M Buy
63,918
+3,574
+6% +$93.6K ﹤0.01% 1839
2022
Q4 		$1.6M Sell
60,344
-5,683
-9% -$185K ﹤0.01% 1638
2022
Q3 		$1.87M Buy
66,027
+4,786
+8% +$123K ﹤0.01% 1633
2022
Q2 		$1.28M Buy
61,241
+22,321
+57% +$418K ﹤0.01% 1831
2022
Q1 		$843K Buy
38,920
+13,752
+55% +$298K ﹤0.01% 2228
2021
Q4 		$699K Buy
+25,168
New +$610K ﹤0.01% 2395
2020
Q2 		– Sell
-11,776
Closed -$79.4K – 2477
2020
Q1 		$79.4K Sell
11,776
-11,640
-50% -$110K ﹤0.01% 2412
2019
Q4 		$272K Buy
+23,416
New +$264K ﹤0.01% 2392
2018
Q1 		– Sell
-10,900
Closed -$139K – 2657
2017
Q4 		$139K Hold
10,900
– – ﹤0.01% 2365
2017
Q3 		$155K Hold
10,900
– – ﹤0.01% 2314
2017
Q2 		$141K Hold
10,900
– – ﹤0.01% 2301
2017
Q1 		$157K Hold
10,900
– – ﹤0.01% 2244
2016
Q4 		$170K Sell
10,900
-14,600
-57% -$200K ﹤0.01% 2162
2016
Q3 		$300K Buy
25,500
+3,900
+18% +$51.4K ﹤0.01% 2263
2016
Q2 		$301K Hold
21,600
– – ﹤0.01% 2222
2016
Q1 		$251K Buy
21,600
+1,300
+6% +$16.5K ﹤0.01% 2307
2015
Q4 		$333K Buy
+20,300
New +$323K ﹤0.01% 2290

Other funds holding CCRN

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

UBS AM's CCRN Position: Q1 2026 in Review

UBS AM increased its Cross Country Healthcare (CCRN) stake by 0.2% in Q1 2026, buying an estimated $1.03K and bringing the position to 57,049 shares worth $536K. The position accounts for ﹤0.01% of the portfolio, ranked #2535.

UBS AM first reported a position in CCRN in Q4 2015 and has held it in 29 quarters since. The position peaked at $1.95M in Q2 2025. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • UBS AM held 57,049 shares of Cross Country Healthcare worth $536K as of Q1 2026.
  • UBS AM bought 115 Cross Country Healthcare shares in Q1 2026, an estimated $1.03K.
  • Cross Country Healthcare made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #2535 holding.
  • UBS AM first reported a position in Cross Country Healthcare in Q4 2015 and has held it in 29 quarters since.
  • UBS AM's Cross Country Healthcare position peaked at $1.95M in Q2 2025.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.